Key Takeaways
- Propella Group and the Thailand Institute of Scientific and Technological Research (TISTR) have signed an MOU to commercialise TISTR's portfolio of research-stage ventures and licensable technologies.
- Propella will apply its proprietary 9P Scale-Up Framework across TISTR's pipeline, covering venture screening, investor-readiness, go-to-market strategy, and cross-border capital access.
- Priority sectors for the partnership include health & wellness, cleantech & sustainability, and food & agritech.
- The collaboration follows a five-phase model — Discover, Diagnose, Execute, Close, and Review & Grow — designed to advance each technology at its own commercialisation pace rather than fixed cohort cycles.
- Propella's investor network spans Tier-1 global venture capital firms, sovereign wealth funds, and leading accelerator platforms, with research links to internationally ranked universities across Asia, the US, and Europe.
Propella Group and TISTR Sign MOU to Commercialise Thai Research Technologies
Propella Group, a cross-border scale-up studio operating across Thailand and Singapore, has signed a Memorandum of Understanding with the Thailand Institute of Scientific and Technological Research (TISTR) to establish a structured commercialisation and scale-up partnership. The agreement covers TISTR's pipeline of research-stage ventures and licensable technologies, with Propella providing the operational framework and capital network needed to bring them to global markets.
A Framework Built Around Each Technology's Readiness
Under the MOU, Propella will deploy its 9P Scale-Up Framework across TISTR's technology portfolio. The partnership is structured around five sequential phases — Discover, Diagnose, Execute, Close, and Review & Grow — intended to be repeatable across technology verticals without relying on fixed cohort timelines. The model is designed to allow each venture to progress according to its own commercialisation readiness, rather than a calendar-driven schedule.
Target sectors include health & wellness, cleantech & sustainability, and food & agritech, areas identified as both research strengths within Thailand and active deployment priorities for global institutional investors.
Propella's Founder on the Mission Behind the Partnership
Thitiphat Thaveesin, Founder and Managing Partner of Propella Group, framed the MOU as central to the studio's broader mandate:
“Thailand has world-class research assets sitting underutilised within its public institutions. Propella's mandate is to change that — by connecting proven science with the institutional capital, market networks, and operational discipline needed to scale globally. This MOU with TISTR is a cornerstone of that mission,” said Thitiphat Thaveesin, Founder & Managing Partner at Propella Group.
Institutional Ecosystem Access for Ventures and Investors
Ventures entering the Propella pipeline through the TISTR partnership gain structured access to a co-investor and syndicate network from day one. That network includes Tier-1 global venture capital firms, sovereign wealth funds, and leading accelerator platforms, as well as research advisory relationships with internationally ranked universities in Asia, the US, and Europe.
The collaboration is structured to deliver defined outcomes on both sides: founders receive operational support, cross-border market entry expertise, and a pathway to institutional capital, while investors gain curated deal flow anchored in government-backed intellectual property with independently verified technical merit.
